These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Studies of cellular immunity of liver diseases. Bacon PA; Berry HW; Brown R Gut; 1971 Oct; 12(10):859. PubMed ID: 5123280 [No Abstract] [Full Text] [Related]
45. Primary biliary cirrhosis and systemic lupus erythematosus. A new case report. Michel F; Toussirot E; Wendling D Rev Rhum Engl Ed; 1998; 65(7-9):504-7. PubMed ID: 9785398 [TBL] [Abstract][Full Text] [Related]
46. Immunological studies on liver diseases. I. Properties of anti-liver antibodies and their appearance in liver diseases. Nakagawa T Naika Hokan; 1969 Mar; 16(3):67-84. PubMed ID: 5815659 [No Abstract] [Full Text] [Related]
47. [Primary biliary liver cirrhosis with a granulomatous reaction]. Popov MS; Rutkovskiĭ OV Arkh Patol; 1982; 44(4):60-3. PubMed ID: 7082202 [TBL] [Abstract][Full Text] [Related]
48. The importance of autoimmune hepatitis and primary biliary cirrhosis in patients with systemic lupus erythematosus. Efe C; Purnak T; Ozaslan E; Ozbalkan Z Lupus; 2011 Jan; 20(1):112. PubMed ID: 21233150 [No Abstract] [Full Text] [Related]
49. Immunologic aspects of liver disease. Kanagasundaram N; Leevy CM Med Clin North Am; 1979 May; 63(3):631-42. PubMed ID: 376975 [No Abstract] [Full Text] [Related]
50. Clinical significance of different antinuclear antibodies patterns in the course of primary biliary cirrhosis. Remmel T; Piirsoo A; Koiveer A; Remmel H; Uibo R; Salupere V Hepatogastroenterology; 1996; 43(11):1135-40. PubMed ID: 8908541 [TBL] [Abstract][Full Text] [Related]
52. [Primary biliary cirrhosis and the overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis]. Wendum D Ann Pathol; 2008 Nov; 28 Spec No 1(1):S54-5. PubMed ID: 18984300 [No Abstract] [Full Text] [Related]
54. [Significance of antinuclear anti-histone antibodies]. Ferec C; Youinou P; Le Goff P; Miossec P; Morin JF; Pennec Y; Morin PP; Le Menn G Ann Med Interne (Paris); 1984; 135(6):427-30. PubMed ID: 6334466 [TBL] [Abstract][Full Text] [Related]
55. Complement metabolism in chronic liver disease: catabolism of C1q in chronic active liver disease and primary biliary cirrhosis. Potter BJ; Elias E; Thomas HC; Sherlock S Gastroenterology; 1980 May; 78(5 Pt 1):1034-40. PubMed ID: 7380176 [TBL] [Abstract][Full Text] [Related]
56. Incorporation of precursors into sterols and proteins in liver biopsies from patients with liver disorders. Evensen SA; Ritland S; Elgjo K; Solberg HE; Skrede S Scand J Gastroenterol; 1984 Jan; 19(1):6-13. PubMed ID: 6143395 [TBL] [Abstract][Full Text] [Related]
57. An inverse relationship between autoimmune liver diseases and Strongyloides stercoralis infection. Aoyama H; Hirata T; Sakugawa H; Watanabe T; Miyagi S; Maeshiro T; Chinen T; Kawane M; Zaha O; Nakayoshi T; Kinjo F; Fujita J Am J Trop Med Hyg; 2007 May; 76(5):972-6. PubMed ID: 17488925 [TBL] [Abstract][Full Text] [Related]
58. [Atypical primary biliary cirrhosis or autoimmune cholangitis?]. Primo J; Miralles A; Ferrando J; Albert A; Julve R; Gómez A; García L Gastroenterol Hepatol; 1999 Dec; 22(10):505-9. PubMed ID: 10650665 [TBL] [Abstract][Full Text] [Related]
59. Autoimmune cholangitis within the spectrum of autoimmune liver disease. Czaja AJ; Carpenter HA; Santrach PJ; Moore SB Hepatology; 2000 Jun; 31(6):1231-8. PubMed ID: 10827147 [TBL] [Abstract][Full Text] [Related]
60. Chronic liver disease. Inhibition of the LE-cell phenomenon in the blood. Holtz G; Schubert JC; Mantel W Med Chir Dig; 1972; 1(4):167-72. PubMed ID: 4118024 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]